Tech Company Financing Transactions

NKT Therapeutics Funding Round

NKT Therapeutics, operating out of Sharon, raised $4 million from private investors.

Transaction Overview

Company Name
Announced On
8/25/2010
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
58 Deborah Sampson St.
Sharon, MA 02067
USA
Email Address
Overview
NKT Therapeutics, Inc. is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease.
Profile
NKT Therapeutics LinkedIn Company Profile
Social Media
NKT Therapeutics Company Twitter Account
Company News
NKT Therapeutics News
Facebook
NKT Therapeutics on Facebook
YouTube
NKT Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Mashal
  Robert Mashal LinkedIn Profile  Robert Mashal Twitter Account  Robert Mashal News  Robert Mashal on Facebook
Chief Scientific Officer
Robert Schaub
  Robert Schaub LinkedIn Profile  Robert Schaub Twitter Account  Robert Schaub News  Robert Schaub on Facebook
VP - Finance
Ron Goldstein
  Ron Goldstein LinkedIn Profile  Ron Goldstein Twitter Account  Ron Goldstein News  Ron Goldstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/25/2010: DriverSide venture capital transaction
Next: 8/26/2010: GroupMe venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary